Controlling Moral Hazard in Health Insurance: 4 Policy Tools & Tradeoffs

Small increases in cost sharing (such as the Medicare Part D donut hole) can significantly increase mortality rates because patients, lacking medical expertise, make haphazard decisions about which medications to cut back on, often discontinuing life-saving drugs like statins and blood pressure medications. Research using the donut hole as a natural experiment found that exposure to this cost-sharing mechanism increased mortality by 30% among 65-year-olds, demonstrating that patients are too responsive to prices and that value-based insurance design (VBID) could help align cost-sharing with clinical value by making beneficial treatments cheaper and less beneficial treatments more expensive.

Value-Based Insurance Design (V-BID) is a healthcare policy approach that aligns patient out-of-pocket costs with the clinical value of services, making high-value care more accessible (lower or no cost-sharing) while discouraging low-value care (higher cost-sharing). This approach addresses the problem of blunt consumer cost-sharing, where patients pay equally for all services regardless of clinical benefit, which disproportionately affects vulnerable populations and reduces access to essential care. V-BID has been successfully implemented in the Affordable Care Act's preventive services section, Medicare Advantage programs, and various state and federal initiatives, demonstrating bipartisan support and broad stakeholder acceptance.

Value-Based Insurance Design (V-BID) is a healthcare reform concept developed at the University of Michigan that restructures health benefit designs by aligning consumer out-of-pocket costs with the clinical value of healthcare services, rather than using a one-size-fits-all cost-sharing model; this approach, which received bipartisan political support and was incorporated into the Affordable Care Act, aims to improve healthcare quality while controlling costs by making high-value preventive services more accessible and reducing financial barriers to beneficial treatments.

Value-based insurance design (VBID) is an approach to health insurance benefit design that aims to improve healthcare value by aligning patient cost-sharing with clinical value. Under VBID, patients pay less (or nothing) for medications and services that provide the greatest health benefits, while paying more for services with lower clinical value. This contrasts with traditional insurance designs where cost-sharing applies uniformly regardless of clinical benefit. VBID recognizes that reducing financial barriers to high-value care can improve health outcomes while potentially reducing overall healthcare spending by encouraging appropriate utilization. Key areas for VBID implementation include pharmaceutical benefits, preventive services, and chronic disease management. Successful VBID requires robust data on clinical effectiveness and careful consideration of how benefit designs impact patient behavior and health outcomes.

Value-based insurance design (VBID) recognizes that traditional benefit structures from the 1960s were designed for acute-care episodes rather than today's population of chronically ill patients with multiple conditions. VBID eliminates cost-sharing for medications and services with high clinical value (diabetes medications, heart failure treatments, COPD therapies, hypertension management, lipid-lowering drugs) while maintaining or increasing cost-sharing for services with marginal clinical benefit. Research shows that eliminating cost-sharing for high-value services increases adherence without increasing overall spending, as reduced hospitalizations offset medication costs.

This section explains value-based payment as a method where purchasers hold healthcare delivery systems accountable for quality and cost. The continuum includes: fee-for-service, pay for performance, shared savings (where ACOs operate), global budget/capitation, and total cost of care. An Accountable Care Organization (ACO) is a group of providers taking collective responsibility for cost and quality of care for a patient population, without needing geographic proximity or patient transfers. In 2023, 456 ACOs covered 10.9 million beneficiaries, with 220 of 1,300 critical access hospitals participating. Rural ACO participation offers lower risk for trialing value-based strategies, networking opportunities, data normalization, and ability to build infrastructure for care coordination and behavioral health integration.

Medicare value-based payments fall into three main categories: (1) Pay-for-Performance models including Value-Based Purchasing ($1.5B in quality bonuses), Readmission Reduction (3% penalty for 6 conditions), and Hospital-Acquired Conditions (1% penalty); (2) Bundled Payments offering fixed payments for 32 care episodes with participating hospitals decreasing from 830 to 715; and (3) Shared Savings through Accountable Care Organizations (ACOs) providing capitated payments for patient populations, currently serving 11.2 million beneficiaries but facing challenges with 56% of hospitals planning to exit.

The Affordable Care Act established the Center for Medicare and Medicaid Innovation (CMMI) to test alternative payment models. Key models include: Bundled Payments (predetermined episode payments with shared savings/risk), Value-Based Purchasing (incentives for quality improvements), and Accountable Care Organizations (provider groups contracting with CMS for quality-based reimbursement). Three payment types exist: Fee-for-service (volume-based), Capitation (fixed per-patient payments), and Value-based/payment (pay-for-performance). These policy frameworks drive the transition toward value-based care, with CMS gaining authority to reform payment structures based on value.

Healthcare provider reimbursement models include fee-for-service (paying per service), bundled payments (paying for entire episodes of care), capitation (fixed payments per patient), global budgets (fixed payments for institutions), and value-based payment (incentivizing quality outcomes). Each model has distinct advantages and disadvantages: fee-for-service offers simplicity but may incentivize quantity over quality; bundled payments encourage efficiency but don't work well for primary care; capitation provides predictability but risks under-treatment; global budgets suit institutional providers; and value-based payment aligns incentives with health outcomes. Oregon's largest healthcare purchaser (OHA) is exploring these models to reduce costs and improve quality, with CCO 2.0 implementing value-based payment approaches. The choice of reimbursement model significantly impacts provider behavior, patient access, and overall healthcare system efficiency.

Accountable Care Organizations (ACOs) represent reform attempts by having multi-specialty physician groups contract directly with Medicare, receiving payments based on performance metrics while bearing financial risk if spending exceeds budgets. Despite theoretical appeal, they haven't significantly reduced costs. Global budgeting models (Maryland, Pennsylvania) set fixed payments to hospitals based on historical spending. Independent at-home demonstration models and rural hospital demonstrations test alternative approaches. These reforms reflect attempts to address fee-for-service incentives driving unnecessary care. However, critics argue these models maintain profit-driven incentives rather than fundamentally transforming care delivery toward population health management.

This comprehensive comparison examines two fundamentally different healthcare systems. The UK NHS provides free care funded through taxation (approximately 20% of income tax), but suffers from long waiting times (6 months for eye appointments). The US system operates like a class system where insurance packages (bronze, silver, gold, platinum) determine care quality and access. The UK GP system provides comprehensive care where one doctor handles all aspects, while the US system requires patients to navigate multiple specialists. The speaker, a British citizen who moved to the US, describes the transition as overwhelming and highlights how healthcare access in the US is directly tied to financial resources, requiring patients to be their own advocates and constantly manage costs through insurance navigation and pharmacy decisions.

Healthcare access models vary significantly between systems. The US requires health insurance, which most Americans have but can still be expensive. The UK NHS is tax-funded and free at point of service, with immigrants paying a health surcharge per person annually for family coverage. Emergency care in the UK allows patients to walk out without bills, while US patients face bills regardless of insurance. Waiting times differ: US patients typically wait 15-30 minutes, while UK patients generally wait slightly longer, typically within an hour of scheduled appointments.

The video provides personal testimony about the UK's National Health Service (NHS) healthcare system. The creator shares that they had wisdom teeth extracted under the NHS for free, and their sister received heart surgery without cost. The creator notes that while wait times exist, they are comparable to those in the US, and that Americans pay more in health insurance premiums. The creator calculates that British people pay less in taxes toward healthcare than Americans pay in health insurance, making the NHS system more cost-effective overall. The creator emphasizes that free healthcare means people can access necessary medical care without financial ruin.

The NHS (National Health Service) represents a universal healthcare system where all citizens receive healthcare regardless of ability to pay. Unlike the US system where patients can schedule appointments in advance, NHS patients must call in the morning to be placed in a phone queue. After waiting approximately an hour and a half, patients receive a call from a receptionist who arranges a phone consultation with a doctor. The doctor determines needed tests, schedules them for the same day, and arranges follow-up consultations. This integrated approach allows patients to be seen, tested, and receive follow-up planning within approximately one hour. The NHS provides universal coverage that protects patients from financial ruin, though it may face challenges like strikes and waiting times. This contrasts with the US system where patients schedule appointments, may be referred to specialists for testing, wait for results, and schedule additional appointments—a process that can take weeks.

This segment presents a comprehensive comparison between US and UK healthcare systems through personal experiences. The speaker recounts an encounter with Kamala Harris at a nursing home where an elderly woman challenged the claim that everyone pays for healthcare through emergency room charges. The speaker then shares their personal experience with Medicaid, describing how their relative received comprehensive healthcare including cataract surgery and specialist visits at no cost. The speaker argues that while Medicaid provides full coverage for eligible individuals, healthcare policies like Obamacare may have unintended consequences for working-class families who faced skyrocketing premium costs. The segment then transitions to personal experiences with the UK NHS, describing how a retired NHS nurse with 40 years of experience waited 4-6 months for a doctor's appointment for a neck lump. The speaker recounts witnessing three friends die from cancer due to delayed diagnosis, suggesting socialized systems may result in later-stage treatment. Additional examples include hospital bed allocation where scheduled patients were reassigned to those in worse condition, ambulances stacked outside hospitals due to insufficient beds, and a wealthy friend traveling to the US for cancer treatment. The segment concludes with a hospital administrator stating the NHS was bankrupt because users weren't contributing through taxes, and two colleagues' wives leaving England to avoid risking pregnancies in the system.